Source comparison
BPC-157 60s Age Specific Protocol: Dosing Comparison
30–50 years 250–300mcg daily 2–3 weeks 300–500mcg daily 4–8 weeks Standard protocol. Faster angiogenic response, higher receptor density supports full-dose initiation 50–60 years 200–250mcg daily 3–4 weeks 250–400mcg daily 6–10 weeks Moderate adjustment. Sligh
This comparison does not assign a generated winner or score.
- 30–50 years
- 250–300mcg daily
- 2–3 weeks
- 300–500mcg daily
- 4–8 weeks
- Standard protocol. Faster angiogenic response, higher receptor density supports full-dose initiation
- 50–60 years
- 200–250mcg daily
- 3–4 weeks
- 250–400mcg daily
- 6–10 weeks
- Moderate adjustment. Slight reduction in fibroblast activity requires slower escalation
- 60+ years
- 150–200mcg daily
- 4–6 weeks
- 200–300mcg daily
- 8–12 weeks
- Significant adjustment. Reduced collagen turnover and capillary density require extended timelines and lower starting doses to avoid transient vascular effects
- Post-surgical (60+)
- 100–150mcg daily
- 6–8 weeks
- 10–14 weeks
- Maximum caution. Compromised tissue integrity and inflammation require ultra-conservative dosing with extended observation